Rating Change
Evercore ISI Group reiterated its Outperform rating on NovoCure Limited (NASDAQ:NVCR) on October 30, 2026.
reiterateNASDAQ:NVCR
Evercore ISI Group Reiterates Outperform Rating on NovoCure Limited (NVCR)
Evercore ISI Group reiterated its Outperform rating on NovoCure Limited (NASDAQ:NVCR) on October 30, 2026.
At publication ·
What changed
NovoCure Limited (NASDAQ:NVCR) · reiterate
- Firm
- Evercore ISI Group
- Rating
- Outperform to Outperform
- Price at event
- $13.02
- Market capitalization
- $1.5B
At a glance
Key takeaways
- Evercore ISI Group reiterated an Outperform rating on NovoCure Limited (NVCR) on October 30, 2026, while the stock trades at $13.02 with a $1.5B market capitalization.
Market Context
NovoCure Limited operates in the Healthcare sector. The stock currently trades at $13.02 with a market capitalization of $1.5B.
Analyst coverage from Evercore ISI Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for NovoCure Limited.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for NovoCure Limited
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 30, 2026 | Evercore ISI Group | Outperform | N/A |
| Jul 24, 2026 | Wedbush | Neutral | N/A |
| Jul 23, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 13, 2026 | JP Morgan | Neutral | N/A |
| Jun 18, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NVCR Stock Page
Frequently Asked Questions
What does the Outperform rating mean for NVCR?
A rating of Outperform from Evercore ISI Group reflects the analyst's outlook on NovoCure Limited (NASDAQ:NVCR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NVCR forecast page.